Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Physician Reinforcement on Risedronate Adherence
NCT00268632Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 1999
- Primary completion
- Feb 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of risedronate in postmenopausal osteoporosis, sponsored by Sanofi. Started Aug 1999; status: completed.
02
Drugs
risedronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00268632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268632.